4-(Trifluoromethoxy)anisole | CAS:710-18-9

We serve 4-(Trifluoromethoxy)anisole CAS:710-18-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-(Trifluoromethoxy)anisole

Chemical Name:4-(Trifluoromethoxy)anisole
CAS.NO:710-18-9
Synonyms:4-(Trifluoromethoxy)anisole
1-methoxy-4-trifluoromethoxybenzene
p-methoxytrifluoromethoxybenzene
4-METHOXY(TRIFLUOROMETHOXY)BENZENE
Hydroquinonemethyltrifluoromethylether;
Molecular Formula:C8H7F3O2
Molecular Weight:192.13500
 
Physical and Chemical Properties:
Density:1.27
Boiling point:164ºC
Flash point:58ºC
Index of Refraction:1.4309-1.4329
 
Specification:
Appearance:Yellow transparent liquid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 4-(Trifluoromethoxy)anisole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Hydroquinonemethyltrifluoromethylether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-methoxy-4-trifluoromethoxybenzene Use and application,4-METHOXY(TRIFLUOROMETHOXY)BENZENE technical grade,usp/ep/jp grade.


Related News: The first is the API – which is the central ingredient.2-Amino-3-bromo-5-fluoropyridine manufacturer The first is the API – which is the central ingredient.2-FLUORO-5-(TRIFLUOROMETHYL)BENZOIC ACID supplier But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China.6-chloropyridine-3-carbonitrile vendor But it has been barred from that body as Beijing has increased pressure on Taiwan under President Tsai Ing-wen, who is skeptical about closer ties with China.Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.